Vol 1, No 1 (September 01, 2012) - Chinese Clinical Oncology

Meng-Chao Wu, Zhao-You Tang, Sheng-Long Ye, Jia Fan, Shu-Kui Qin, Jia-Mei Yang, Min-Shan Chen, Min-Hua Chen, Ming-De Lv, Kuan-Sheng Ma, Yu-Lian Wu, Yi Chen, Guo-Jun Qian, Shi-Chun Lu, Jia-Sheng Zheng, Wen-Bing Sun, Ying-Hua Zou, Hui-Min Liang, Zhi-Yong Huang, Xin-Wei Han, Xiang Jing, Hong-Ming Pan, Tian-An Jiang, Ping Liang, Zheng-Gang Ren, Yao-Jun Zhang

PDF Pages: 11 Full Text (4377) Open Access

Expert consensus on the scheme of pathological diagnosis of primary liver cancer

Wen-Ming Cong, Xi-Qi Hu, Yun-Tian Sun, Yun-Shan Tan, Xiao-Long Ji, Jing-Ping Yun, Hong-Guang Zhu, Hui Guo, Rui-Aan Wang, Su-Xiang Liu, Hong-Lin Yin, Xi Wang, Zeng-Shan Li, Yuan Ji

PDF Pages: 12 Full Text (5021) Open Access

Vol 1, No 1 (September 01, 2012): Chinese Clinical Oncology

Editorial

Chinese Clinical Oncology: a new oncology journal for oncology physicians and researchers worldwide

Medical oncology in Asia

Advanced clinical trials for China

Perspective

Serum Dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma

Who will be the next rising star? —— Any hope to find a reliable biomarker for HCC?

Vitamin E: potential therapeutical approach for prevention of liver cancer development

Vitamin intake and risk of liver cancer: potential for prevention?

Vitamin E in prevention against hepatocellular carcinoma: right type, right dose and right population

Hepatocellular carcinoma: expanding the horizon

Guidelines and Expert Consensus

Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition)

Expert consensus on local ablation therapies for primary liver cancer

Expert consensus on the scheme of pathological diagnosis of primary liver cancer

Perspective

Current status of bevacizumab for advanced hepatocellular carcinoma

Hepatocellular carcinoma: present and future

Guidelines for the management of hepatocellular carcinoma: still in need of standardization